Results 131 to 140 of about 101,157 (242)
ABSTRACT Bedaquiline is approved for use in a thrice‐weekly dosing schedule; simpler once‐daily dosing strategies could enable fixed‐dose combinations and improve patient adherence. We developed an interactive R Shiny simulation tool to enable the evaluation of different bedaquiline dosing schedules within an integrated dose‐pharmacokinetic‐efficacy ...
Yu‐Jou Lin +3 more
wiley +1 more source
A Bourdieusian Approach to the Demobilisation of Brazil's AIDS Movement
ABSTRACT This article offers a Bourdieusian analysis of the demobilization of Brazil's AIDS movement, once a globally celebrated force in shaping innovative, rights‐based public health responses. Drawing on extensive qualitative data, I argue that the movement's decline cannot be explained solely by institutional co‐optation, biomedicalisation, or ...
Helena de Moraes Achcar
wiley +1 more source
Demissie Assegu Fenta,1 Metsihet Mohammed Nuru,1 Tilahun Yemane,2 Yaregal Asres,3 Temesgen Bizuayehu Wube1 1School of Medical Laboratory, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia; 2School of Medical Laboratory ...
Fenta DA +4 more
doaj
Tenofovir, Interferon Pathways, and Mucosal Immunity: Implications for People Living With HIV
ABSTRACT Background Antiretroviral therapy (ART) suppresses HIV replication and protects people living with HIV (PLWH) from progressing to AIDS. However, despite ART, many PLWH experience chronic immune activation, which contributes to premature aging and non‐AIDS‐related comorbidities. One reason for this chronic immune activation (CIA) is HIV and its
Florian Hladik +5 more
wiley +1 more source
Despite effective ART, neurocognitive impairment persists in people with HIV. Brains from PWH present exacerbated microgliosis and formation of microglial nodules that are actively engaged in neuronal phagocytosis, resulting in neuronal injury and dendritic loss.
Roberta S. Dos Reis +12 more
wiley +1 more source
Considerations for the Use of AAV‐based Gene Therapy in HIV‐Positive Individuals With Haemophilia
ABSTRACT Introduction There is a high prevalence of human immunodeficiency virus (HIV) infection among the haemophilia community due to treatment in the 1970s and 1980s with contaminated clotting factor. Lifelong treatment regimens for haemophilia and HIV are burdensome alone and pose a particular challenge for individuals living with both conditions ...
Jürgen K. Rockstroh +5 more
wiley +1 more source
How Vaccinating People Living With HIV May Guide bNAb‑Based Vaccines
Journal of the International AIDS Society, Volume 29, Issue 5, May 2026.
Penny L. Moore +2 more
wiley +1 more source
ABSTRACT Calciphylaxis is a rare, life‐threatening disorder primarily affecting patients with end‐stage renal disease (ESRD) on dialysis. Early lesions can mimic infection, leading to delays in diagnosis and wound‐directed care. We describe an atypical early presentation of calciphylaxis in a patient with ESRD and sarcoidosis, initially misdiagnosed as
Nicole Nowak +3 more
wiley +1 more source
ABSTRACT Aims To develop a conceptual model integrating Robinson's Theory of Trust and Watson's Caritas Processes to guide trust‐building approaches and caring practices that support adolescents and young adults with HIV during the healthcare transition from paediatric to adult care.
Emily Anne Barr, Sara Horton‐Deutsch
wiley +1 more source
How Much Does It Cost to Provide Antiretroviral Therapy for HIV/AIDS in Africa? [PDF]
Background: Many African countries are rapidly expanding HIV/AIDS treatment programs. Empirical information on the cost of delivering antiretroviral therapy (ART) for HIV/AIDS is needed for program planning and budgeting.
Long, Lawrence, Rosen, Sydney
core +1 more source

